Full Text View
Tabular View
Study Results
Related Studies
Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis
This study has been completed.
Study NCT00051558   Information provided by Eli Lilly and Company
First Received: January 13, 2003   Last Updated: February 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Osteoporosis
More general conditions related to this trial
Bone Diseases
Bone Diseases, Metabolic
Musculoskeletal Diseases
Interventions listed in this trial
Teriparatide
Alendronate Sodium
Placebo
Additional drug interventions recognized in this trial
Alendronate
Glucocorticoids
More general drug interventions related to this trial
Bone Density Conservation Agents
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services